selected publications
-
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
Gastroenterology.
2021
Academic Article
GET IT
Times cited: 27 -
No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
2021
Academic Article
GET IT
Times cited: 7 - Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease. Crohn's & colitis 360. 2020 Academic Article GET IT
-
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
Cell host & microbe.
2019
Academic Article
GET IT
Times cited: 255 -
Plasmablastic Lymphoma in a Patient With Crohn's Disease After Extensive Immunosuppressive Therapy.
2017
GET IT
Times cited: 3 -
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Inflammatory bowel diseases.
2017
Academic Article
GET IT
Times cited: 79 -
IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation.
Science translational medicine.
2017
Academic Article
GET IT
Times cited: 204 -
The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
Inflammatory bowel diseases.
2015
Academic Article
GET IT
Times cited: 62 -
Treatment of metastatic cutaneous Crohn disease with certolizumab.
2015
GET IT
Times cited: 7 -
Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab.
Journal of digestive diseases.
2011
Academic Article
GET IT
Times cited: 25 -
Escherichia coli O157:H7: etiology, clinical features, complications, and treatment.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
2001
Review
GET IT
Times cited: 21